<70 Years (n = 13) |
| ≥70 Years (n = 16) |
| p Values* | |||||||
Grade 1 - 2 | Grade ≥ 3 | Grade 1 - 2 | Grade ≥ 3 | ||||||||
n | (%) | n | (%) | n | (%) | n | (%) | ||||
Related to capecitabine and oxaliplatin | |||||||||||
Leukocytopenia | 2 | (15.4%) | 0 | (0.0%) | 1 | (6.3%) | 0 | (0.0%) | 0.421 | ||
Thrombocytopenia | 2 | (15.4%) | 0 | (0.0%) | 2 | (12.5%) | 0 | (0.0%) | 0.823 | ||
Grade 1 | Grade ≥ 2 | Grade 1 | Grade ≥ 2 | ||||||||
Nausea and vomiting | 2 | (15.4%) | 0 | (0.0%) | 1 | (6.3%) | 1 | (6.3%) | 0.411 | ||
Fatigue | 1 | (7.7%) | 0 | (0.0%) | 2 | (12.5%) | 1 | (6.3%) | 0.483 | ||
Aphtha | 0 | (0.0%) | 0 | (0.0%) | 0 | (0.0%) | 0 | (0.0%) | - | ||
Diarrhea | 1 | (7.7%) | 0 | (0.0%) | 1 | (6.3%) | 0 | (0.0%) | 0.879 | ||
Hand-foot syndrome | 0 | (0.0%) | 3 | (23.1%) | 0 | (0.0%) | 3 | (18.8%) | 0.775 | ||
Peripheral neuropathy | 6 | (46.2%) | 1 | (7.7%) | 1 | (6.3%) | 1 | (6.3%) | 0.031 | ||